OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: MGN 34.5%
Megan Holdings Limited Announces Closing of $8.3 Million Follow-on Public Offering
NASDAQ: BWIN 28.55%
Baldwin (BWIN) Q4 2025 Earnings Call Transcript
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
NASDAQ: PSKY 24.52%
Warner Bros Discovery Deal: Why Netflix May Have Still Won
NASDAQ: ACXIF 31.15%
NASDAQ: MGN 31.15%
NASDAQ: BWIN 31.15%
NASDAQ: BATL 31.15%
